Theasinensin C

CAS No. 89013-69-4

Theasinensin C( —— )

Catalog No. M37863 CAS No. 89013-69-4

Theasinensin C is a compound extracted from black tea water with an IC50 value of 40.21 μM for renin activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1386 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Theasinensin C
  • Note
    Research use only, not for human use.
  • Brief Description
    Theasinensin C is a compound extracted from black tea water with an IC50 value of 40.21 μM for renin activity.
  • Description
    Theasinensin C is a compound extracted from black tea water with an IC50 value of 40.21 μM for renin activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    RAAS
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    89013-69-4
  • Formula Weight
    610.52
  • Molecular Formula
    C30H26O14
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC=1C=C(O)C2=C(OC(C=3C=C(O)C(O)=C(O)C3C4=C(O)C(O)=C(O)C=C4C5OC=6C=C(O)C=C(O)C6CC5O)C(O)C2)C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Benazepril hydrochlo...

    Benazepril, brand name Lotensin, is a medication used to treat high blood pressure (hypertension), congestive heart failure, and chronic renal failure.

  • Zofenopril (calcium)

    Zofenopril Calcium(SQ26991) is an antioxidant that acts as an angiotensin-converting enzyme inhibitor. ACE Zofenopril is a pro-drug designed to undergo metabolic hydrolysis yielding the active free sulfhydryl compound zofenoprilat which is an angiotensin converting enzyme (ACE) inhibitor.

  • FPL-62129

    FPL-62129 is a calcium channel antagonist and a novel angiotensin-converting enzyme inhibitor with vasodilator activity for the study of cardiovascular disease.